Trade Chinook Therapeutics, Inc. - KDNY CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 40.26 |
| Open | 40.28 |
| 1-Year Change | 107.42% |
| Day's Range | 40.24 - 40.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Aug 10, 2023 | 40.34 | 0.09 | 0.22% | 40.25 | 40.45 | 40.24 |
| Aug 9, 2023 | 40.26 | 0.03 | 0.07% | 40.23 | 40.27 | 40.22 |
| Aug 8, 2023 | 40.27 | 0.04 | 0.10% | 40.23 | 40.32 | 40.23 |
| Aug 7, 2023 | 40.27 | 0.06 | 0.15% | 40.21 | 40.33 | 40.20 |
| Aug 4, 2023 | 40.23 | 0.02 | 0.05% | 40.21 | 40.24 | 40.20 |
| Aug 3, 2023 | 40.24 | 0.09 | 0.22% | 40.15 | 40.25 | 40.15 |
| Aug 2, 2023 | 40.14 | -0.10 | -0.25% | 40.24 | 40.27 | 40.07 |
| Aug 1, 2023 | 40.24 | -0.01 | -0.02% | 40.25 | 40.41 | 40.21 |
| Jul 31, 2023 | 39.12 | 0.13 | 0.33% | 38.99 | 39.22 | 38.90 |
| Jul 28, 2023 | 39.02 | 0.07 | 0.18% | 38.95 | 39.05 | 38.90 |
| Jul 27, 2023 | 38.89 | -0.15 | -0.38% | 39.04 | 39.10 | 38.84 |
| Jul 26, 2023 | 39.03 | -0.01 | -0.03% | 39.04 | 39.07 | 38.86 |
| Jul 25, 2023 | 39.03 | -0.07 | -0.18% | 39.10 | 39.18 | 39.01 |
| Jul 24, 2023 | 39.19 | 0.31 | 0.80% | 38.88 | 39.31 | 38.86 |
| Jul 21, 2023 | 38.84 | -0.20 | -0.51% | 39.04 | 39.20 | 38.81 |
| Jul 20, 2023 | 39.04 | -0.12 | -0.31% | 39.16 | 39.27 | 38.95 |
| Jul 19, 2023 | 39.15 | -0.16 | -0.41% | 39.31 | 39.39 | 39.13 |
| Jul 18, 2023 | 39.29 | -0.04 | -0.10% | 39.33 | 39.48 | 39.28 |
| Jul 17, 2023 | 39.33 | 0.17 | 0.43% | 39.16 | 39.35 | 39.12 |
| Jul 14, 2023 | 39.18 | 0.08 | 0.20% | 39.10 | 39.19 | 39.02 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Chinook Therapeutics, Inc. Company profile
About Chinook Therapeutics Inc
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing precision medicines for kidney diseases. The Company's development programs consist of Atrasentan, BION-1301 and CHK-336. Atrasentan is a potent and selective endothelin A receptor antagonist that are developed for the treatment of proteinuric glomerular diseases. BION-1301 is an investigational humanized IgG4 monoclonal antibody that blocks APRIL binding to both the B-cell maturation antigen (BCMA), and transmembrane activator and CAML interactor (TACI), receptors, as a disease-modifying therapy for Immunoglobulin A Nephropathy (IgAN). CHK-336 is a liver-targeted oral small molecule lactate dehydrogenase (LDHA), inhibitor, which are developed for the treatment of primary hyperoxaluria.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Chinook Therapeutics Inc revenues increased from $827K to $51.6M. Net loss increased 26% to $102.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and Development-other increase from $24.8M to $66.1M (expense), Change in fair value of contingent consi increase from $1.5M to $27.3M (expense).
| Industry: | Bio Therapeutic Drugs |
400 Fairview Avenue North, Suite 900
SEATTLE
WASHINGTON 98109
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com